CAMP and rosacea: Notably, elevated LL37 expression has been consistently observed in rosacea lesions, and intradermal injections of LL37 in mice induce rosacea-like phenotypes, strongly implicating LL37 as a central mediator of disease pathogenesis (9, 10).